Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
Changrui Lu(Donghua University), Xiaoming Yang(China National Biotechnology (China))
Cited by 10
Related Papers
In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents
|Molecules|2023|3
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1